Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egidio Brocca-Cofano

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Opinion in Virology|August 14, 2017
Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART eraTianyu He, Elizabeth Falwell, Egidio Brocca-Cofano, et al.
International Journal of Molecular Sciences|February 26, 2022
Kaposi's Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat AntibodiesEgidio Brocca-Cofano, Cecilia Sgadari, Orietta Picconi, et al.
Virology Journal|July 16, 2008
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c miceSilvia Cellini, Cinzia Fortini, Eleonora Gallerani, et al.
Journal of Cellular Physiology|May 1, 2010
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccinationArianna Castaldello, Marco Sgarbanti, Giulia Marsili, et al.
Virology|July 8, 2015
Loss of marginal zone B-cells in SHIVSF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infectionThorsten Demberg, Venkatramanan Mohanram, Thomas Musich, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivativeSara Richter, Cristina Parolin, Barbara Gatto, et al.
AIDS Research and Human Retroviruses|May 7, 2021
Lack of Specific Regulatory T Cell Depletion and Cytoreduction Associated with Extensive Toxicity After Administration of Low and High Doses of CyclophosphamideAdam J Kleinman, Ranjit Sivanandham, Paola Sette, et al.
The Journal of Clinical Investigation|September 12, 2018
Neutrophil extracellular trap production contributes to pathogenesis in SIV-infected nonhuman primatesRanjit Sivanandham, Egidio Brocca-Cofano, Noah Krampe, et al.
Frontiers in Immunology|December 28, 2020
Pharmacokinetics and Immunological Effects of Romidepsin in Rhesus MacaquesAdam J Kleinman, Cuiling Xu, Mackenzie L Cottrell, et al.
Vaccine|February 5, 2008
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxinAntonella Caputo, Egidio Brocca-Cofano, Arianna Castaldello, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Opinion in Virology|August 14, 2017
Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART eraTianyu He, Elizabeth Falwell, Egidio Brocca-Cofano, et al.
International Journal of Molecular Sciences|February 26, 2022
Kaposi's Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat AntibodiesEgidio Brocca-Cofano, Cecilia Sgadari, Orietta Picconi, et al.
Virology Journal|July 16, 2008
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c miceSilvia Cellini, Cinzia Fortini, Eleonora Gallerani, et al.
Journal of Cellular Physiology|May 1, 2010
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccinationArianna Castaldello, Marco Sgarbanti, Giulia Marsili, et al.
Virology|July 8, 2015
Loss of marginal zone B-cells in SHIVSF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infectionThorsten Demberg, Venkatramanan Mohanram, Thomas Musich, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivativeSara Richter, Cristina Parolin, Barbara Gatto, et al.
AIDS Research and Human Retroviruses|May 7, 2021
Lack of Specific Regulatory T Cell Depletion and Cytoreduction Associated with Extensive Toxicity After Administration of Low and High Doses of CyclophosphamideAdam J Kleinman, Ranjit Sivanandham, Paola Sette, et al.
The Journal of Clinical Investigation|September 12, 2018
Neutrophil extracellular trap production contributes to pathogenesis in SIV-infected nonhuman primatesRanjit Sivanandham, Egidio Brocca-Cofano, Noah Krampe, et al.
Frontiers in Immunology|December 28, 2020
Pharmacokinetics and Immunological Effects of Romidepsin in Rhesus MacaquesAdam J Kleinman, Cuiling Xu, Mackenzie L Cottrell, et al.
Vaccine|February 5, 2008
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxinAntonella Caputo, Egidio Brocca-Cofano, Arianna Castaldello, et al.
Pageof 5